Status:
UNKNOWN
High Energy Formula Feeding in Infants With Congenital Heart Disease
Lead Sponsor:
Dr. Sami Ulus Children's Hospital
Conditions:
Growth Failure
Neurodevelopmental Disorder
Eligibility:
All Genders
8-6 years
Phase:
NA
Brief Summary
High energy formula more positively affect growth in infants with congenital heart disease compared to standard formula
Detailed Description
Infants with congenital heart disease (CHD) usually show growth retardation as they can not intake enough calorie due to fluid restriction. We hypothesize that high energy formula more positively affe...
Eligibility Criteria
Inclusion
- infants \>35 weeks of gestational age
- infants with CHD
- İnfants fed with formula feeding
Exclusion
- Major congenital abnormalities except CHD
- infants could not be fed enterally
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2014
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01850784
Start Date
February 1 2013
End Date
October 1 2014
Last Update
May 10 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sami Ulus CH
Ankara, Turkey (Türkiye)